Interindividual differences in hepatic expression of CYP3A4:: Relationship to genetic polymorphism in the 5′-upstream regulatory region

被引:249
作者
Westlind, A
Löfberg, L
Tindberg, N
Andersson, TB
Ingelman-Sundberg, M
机构
[1] Karolinska Inst, IMM, Div Mol Toxicol, Inst Environm Med, S-17177 Stockholm, Sweden
[2] Astra Hassle AB, Dept Pharmacokinet & Drug Metab, S-41683 Molndal, Sweden
关键词
nifedipine; testosterone hydroxylase; pregnenolone X receptor; leukaemia; prostate cancer;
D O I
10.1006/bbrc.1999.0752
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 3A4, the most abundant P450 form in human liver, exhibits a very broad substrate specificity and is of great importance for drug metabolism. The interindividual difference in the hepatic expression of CYP3A4 is considerable. In order to investigate possible genetic factor(s) causing this variation, the rate of GP-hydroxylation of testosterone in human liver microsomes prepared from 46 different human liver samples was determined and the 5' upstream region (+10 to -490 bp) was sequenced from genomic DNA isolated from 39 of these livers. We found a 31-fold variation of the testosterone hydroxylase activity between the samples. However, a very high sequence homology between the CYP3A4 5'-upstream regions sequenced from the 78 different alleles was found. In fact, only three variant nucleotide exchanges were identified, all causing a -290 A-->G mutation (CYP3A4-V) in a so called nifedipine specific element (NFSE). The importance of this element and the polymorphism was evaluated by gel shift analysis. Competition experiments revealed that the binding of nuclear proteins, although having lower affinity to the CYP3A4-V form of the element, was unspecific in nature. In accordance, no influence of this polymorphism was seen on the microsomal testosterone hydroxylase activity in vitro. It is concluded that the promoter region of CYP3A4 is highly conserved, the only polymorphism being in the NFSE, which however does not influence the enzyme expression in liver to a significant degree. This casts doubt of a previously described relationship between the CYP3A4-V allele and cancer in the prostate and leukaemia. (C) 1999 Academic Press.
引用
收藏
页码:201 / 205
页数:5
相关论文
共 20 条
  • [1] Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction
    Bertilsson, G
    Heidrich, J
    Svensson, K
    Åsman, M
    Jendeberg, L
    Sydow-Bäckman, M
    Ohlsson, R
    Postlind, H
    Blomquist, P
    Berkenstam, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) : 12208 - 12213
  • [2] Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions
    Bertz, RJ
    Granneman, GR
    [J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 210 - 258
  • [3] SXR, a novel steroid and xenobiotic-sensing nuclear receptor
    Blumberg, B
    Sabbagh, W
    Juguilon, H
    Bolado, J
    van Meter, CM
    Ono, ES
    Evans, RM
    [J]. GENES & DEVELOPMENT, 1998, 12 (20) : 3195 - 3205
  • [4] HUMAN-LIVER MICROSOMAL CYTOCHROME-P-450IIE1 - IMMUNOLOGICAL EVALUATION OF ITS CONTRIBUTION TO MICROSOMAL ETHANOL OXIDATION, CARBON-TETRACHLORIDE REDUCTION AND NADPH OXIDASE ACTIVITY
    EKSTROM, G
    VONBAHR, C
    INGELMANSUNDBERG, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (04) : 689 - 693
  • [5] ENZYME-STRUCTURE RELATIONSHIPS IN ENDOPLASMIC RETICULUM OF RAT LIVER - A MORPHOLOGICAL AND BIOCHEMICAL STUDY
    ERNSTER, L
    PALADE, GE
    SIEKEVITZ, P
    [J]. JOURNAL OF CELL BIOLOGY, 1962, 15 (03) : 541 - +
  • [6] Association of CYP3A4 genotype with treatment-related leukemia
    Felix, CA
    Walker, AH
    Lange, BJ
    Williams, TM
    Winick, NJ
    Cheung, NKV
    Lovett, BD
    Nowell, PC
    Blair, IA
    Rebbeck, TR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) : 13176 - 13181
  • [7] Guengerich F. Peter, 1995, P473
  • [8] GENE STRUCTURE OF CYP3A4, AN ADULT-SPECIFIC FORM OF CYTOCHROME-P450 IN HUMAN LIVERS, AND ITS TRANSCRIPTIONAL CONTROL
    HASHIMOTO, H
    TOIDE, K
    KITAMURA, R
    FUJITA, M
    TAGAWA, S
    ITOH, S
    KAMATAKI, T
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (02): : 585 - 595
  • [9] LEMOINE A, 1993, MOL PHARMACOL, V43, P827
  • [10] LOWRY OH, 1951, J BIOL CHEM, V193, P265